Albert Lowe

Stock Analyst at Craig-Hallum

(1.98)
# 2,988
Out of 4,883 analysts
9
Total ratings
44.44%
Success rate
6.25%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Albert Lowe

Neurogene
Jun 17, 2025
Initiates: Buy
Price Target: $50
Current: $19.50
Upside: +156.41%
Atossa Therapeutics
Jun 5, 2025
Initiates: Buy
Price Target: $4
Current: $0.85
Upside: +372.93%
Opus Genetics
Apr 11, 2025
Initiates: Buy
Price Target: $6
Current: $0.99
Upside: +504.78%
Skye Bioscience
Mar 21, 2025
Maintains: Buy
Price Target: $18$14
Current: $4.39
Upside: +218.91%
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $1.96
Upside: +461.22%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $3.65
Upside: +119.18%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $0.95
Upside: +320.88%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.20
Upside: +400.00%